|
Real-time Estimate
Tradegate
15:44:17 18/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 58.70 EUR | +0.43% |
|
+1.83% | -7.66% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.28% | +2.62% | -2.60% | +3.64% | +7.24% | +51.61% | +100.19% | +400.84% | +1,362.49% | 1,027B | |
| +1.10% | +1.45% | +2.99% | +15.38% | +30.57% | +52.49% | +67.37% | +64.02% | +128.52% | 651B | |
| +0.58% | +3.54% | +5.47% | +19.34% | +15.55% | +19.57% | +73.56% | +145.08% | +317.29% | 467B | |
| +0.40% | +5.35% | +0.47% | +13.67% | +10.48% | +38.66% | +40.57% | +6.18% | +49.53% | 350B | |
| +0.24% | +3.95% | -7.25% | -1.34% | +6.26% | +20.43% | +26.56% | +50.84% | +48.17% | 268B | |
| +0.47% | +6.90% | +6.01% | -4.85% | -9.24% | +11.27% | +16.67% | +46.23% | +146.43% | 257B | |
| +0.91% | -0.70% | -9.44% | +11.16% | +16.03% | +38.25% | +45.67% | +73.12% | +119.58% | 205B | |
| +0.44% | +1.57% | -5.25% | +0.25% | -13.67% | -28.46% | -56.83% | -11.48% | +81.87% | 190B | |
| +2.17% | +4.20% | +8.62% | +20.28% | +22.93% | +34.41% | +99.41% | +110.71% | +91.48% | 187B | |
| +0.66% | -0.04% | +2.87% | +6.64% | +11.00% | +14.93% | -18.87% | -37.02% | -18.56% | 158B | |
| +0.60% | +0.35% | +0.15% | +12.49% | +13.89% | +33.37% | +47.99% | +174.21% | +456.94% | 131B | |
| -1.19% | -1.43% | -2.77% | +13.68% | +16.50% | +36.16% | +6.45% | +2.50% | +13.02% | 128B | |
| -0.37% | +2.36% | -3.45% | +2.25% | -9.34% | -6.44% | -26.25% | -8.56% | +7.70% | 104B | |
| -0.86% | +6.64% | 0.00% | -1.82% | +3.48% | +28.17% | +25.42% | +7.58% | -8.21% | 102B | |
| +0.93% | +5.05% | -1.48% | -10.84% | -18.16% | -0.33% | +51.32% | +63.38% | +480.72% | 70.58B | |
| +0.37% | +5.33% | +4.67% | +18.48% | +23.43% | +34.11% | +23.59% | +58.77% | +28.51% | 60.94B | |
| -0.89% | +0.98% | -0.21% | +30.93% | +31.42% | +76.55% | -0.01% | +7.44% | -46.90% | 55.31B | |
| +1.71% | +5.92% | +5.92% | +29.17% | +36.98% | +173.67% | +282.34% | +325.05% | -23.75% | 45.67B | |
| -0.67% | +0.70% | -18.23% | -8.00% | -27.43% | -38.36% | -0.85% | -7.92% | +173.04% | 42.47B | |
| Average | +0.17% | +2.20% | -0.71% | +8.97% | +8.84% | +31.06% | +42.33% | +77.42% | +179.36% | 236.79B | |
| Weighted average by Cap. | -0.09% | +2.43% | -0.06% | +8.81% | +11.12% | +34.07% | +54.64% | +138.36% | +412.15% |
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
